Vu Technologies and Moffitt Cancer Center Use NVIDIA DGX Spark for 3D Tumor Visualization

Vu Technologies and Moffitt Cancer Center have introduced a 3D microscopy visualizer built on the NVIDIA DGX Spark platform, announced in a press release. The tool allows researchers to analyze high resolution three dimensional microscopy data of patient derived microtumors to support cancer research.

Vu Technologies developed a proprietary inference driven semantic media server that replaces traditional rendering with AI based visualization on the DGX Spark. This approach enables procedurally generated visuals faster than real time. The company’s proprietary vu.ai shader library supports this process by creating content dynamically through local AI inference.

The collaboration began in early 2026 and the tumor cell visualizer is already in use by researchers at Moffitt. Vu plans to expand this approach by hosting additional enterprise data visualization tools, including Vu Intelligence, on the DGX Spark to enhance on premises capabilities.

Moffitt’s Bioengineering Department chair, Greg Sawyer, said that AI visualization platforms like this can make complex tumor imaging more interactive and accessible for scientists. The joint effort aims to improve how researchers interpret biomedical data and accelerate the study of potential cancer treatments.